Track topics on Twitter Track topics that are important to you
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200212005375/en/
Technavio has published a new market research report on the cell viability assays market from 2020-2024. (Graphic: Business Wire)
Read the 147-page report with TOC on "Cell Viability Assays Market Analysis Report by Product (Consumables and Instruments), Geographic segmentation (North America, Europe, Asia and ROW), and the Segment Forecasts, 2020-2024".
The market is driven by the rising emphasis on timely diagnosis of diseases. In addition, the growing focus on stem cell research is anticipated to boost the growth of the cell viability assays market.
The need for preventive diagnosis is increasing among patients with high risk of genetic diseases or a family history of specific diseases. Preventive healthcare requires a timely diagnosis of diseases to halt further progress of the disease by frequent monitoring. The use of cell viability assays is an approach to obtain accurate diagnosis for preventive care and effective treatment of patients. They are generally based on numerous factors such as cell adherence, permeability of cell membranes, ATP production, nucleotide uptake activity, enzyme activity, and co-enzyme production. Cell viability assays have become a necessity in cancer diagnosis for the determination of appropriate chemotherapeutic treatment regimen. This is propelling the demand and sales of consumables and instruments required for cell viability assays. Thus, the growing emphasis on timely diagnosis of diseases is expected to drive market growth during the forecast period.
Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.
Major Five Cell Viability Assays Market Companies:
Agilent Technologies Inc.
Agilent Technologies Inc. is headquartered in the US and operates the business under various segments such as Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The company offers Synergy LX and Cytation 7.
Becton, Dickinson and Co.
Becton, Dickinson and Co. is headquartered in the US and offers products through the following business units: BD Medical, BD Life Sciences, and BD Interventional. The company offers BD Via-Probe, BD Horizon Fixable Viability Stain, and BD Pharmingen.
Bio-Rad Laboratories Inc.
Bio-Rad Laboratories Inc. is headquartered in the US and operates under various business segments, namely Life Science and Clinical Diagnostics. The company offers ReadiDrop 7-AAD Solution, ReadiDrop Propidium Iodide Solution, and VivaFix.
Biotium Inc. is headquartered in the US and offers a wide selection of assay kits for cell viability and proliferation including Live-or-Dye dead cell stains for flow or microscopy.
Danaher Corp. is headquartered in the US and offers products through the following business segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions. The company offers Vi-CELL XR Cell Viability Analyzer System.
Register for a free trial today and gain instant access to 17,000+ market research reports.
Cell Viability Assays Market Product Outlook (Revenue, USD Billion, 2020-2024)
Cell Viability Assays Market Geographic Outlook (Revenue, USD Billion, 2020-2024)
Technavio’s sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more. Request a free sample report
Related Reports on Health Care Include:
In-vitro Toxicity Testing Market – Global In-vitro Toxicity Testing Market by end-users (pharmaceutical and biotechnology companies, academic and research institutions, and others) and geography (Asia, Europe, North America, and ROW).
Genetic Testing Market – Global Genetic Testing Market by geography (Asia, Europe, North America, and ROW), product (equipment and consumables), end-user (clinical diagnostics laboratories, hospitals, and biopharmaceutical companies and research centers), and application (predictive and diagnostic testing, prenatal, newborn, and preimplantation testing; pharmacogenomic testing; and forensic, relationship, and ancestry testing).
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Immunoassay - ELISA
Immunoassays are quick and accurate tests to detect specific molecules. Immunoassays rely on an antibody to bind to the specific structure of a molecule. Antibodies are proteins generated by animals in response to the invasion of a foreign molecule (anti...
Track and monitor developments in stem cell research and commercial development. Follow the tabs above to read the latest global news, research, clinical trials on stem cells and follow companies active in the stem cell industry. BioPort...